Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience
Open Access
- 22 February 2020
- journal article
- research article
- Published by Springer Nature in Journal of the Egyptian National Cancer Institute
- Vol. 32 (1) , 1-8
Abstract
Background: Hepatic complications are a well-known cause of both early and late mortality and morbidity in hematopoietic stem cell transplant (HSCT) recipients. Early diagnosis and management of hepatic complications is important in order to commence appropriate therapy. Conditioning regimens, acute and chronic graft versus host disease, sinusoidal obstruction syndrome, and infections among others represent major hepatic complications for the transplant recipient. We assessed liver function tests, viral markers, polymerase chain reaction, abdominal ultrasound, portal, and hepatic venous duplex in 88 patients underwent autologous and 102 patients underwent allogeneic transplant as well as liver biopsy in selected patients in this retrospective study and evaluated early and late hepatic complications and their impact on transplant outcome. Results: The major cause of hepatic injury in allogeneic patients is the conditioning regimen (38.8%) followed by acute GVHD (14.7%), after day +100 chronic hepatic GVHD is the primary cause of liver injury which occurred in about 40% of allogeneic patients. In autologous patients, the first cause of hepatotoxicity is also conditioning regimen involving 27.9% of patients followed by flare of viral hepatitis in 7.9% and sepsis in 6.3% of cases. The prevalence of HCV, HBV, and CMV is 19%, 16%, and 8%, respectively. Conclusion: In our study, conditioning regimens, acute and chronic hepatic GVHD are frequent causes of hepatic injury following allogeneic HSCT while conditioning regimens, flare of viral hepatitis, and sepsis represent the most common causes of hepatic injury following autologous HSCT.Keywords
This publication has 17 references indexed in Scilit:
- Late effects of blood and marrow transplantationHaematologica, 2017
- Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTBone Marrow Transplantation, 2017
- How I treat hepatitis C virus infection in patients with hematologic malignanciesBlood, 2016
- Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 PatientsTransplantation and Cellular Therapy, 2011
- A Risk Score for Mortality after Allogeneic Hematopoietic Cell TransplantationAnnals of Internal Medicine, 2006
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Liver disease is a major cause of mortality following allogeneic bone-marrow transplantationEuropean Journal of Gastroenterology & Hepatology, 2004
- Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalenceHepatology, 2000
- Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective studyBone Marrow Transplantation, 2000
- Liver disease complicating bone marrow transplantation: A clinical auditJournal of Gastroenterology and Hepatology, 1995